PEGS meeting, Boston (USA), April 30 – May 4, 2018

Meet our team booth #521 during the Protein & Antibody Engineering Summit (PEGS) in Boston (MA, United States), April 30 – May 4, 2018.

General information

PEGS Boston features nearly 400 presentations by world renowned leaders from pharma, academia, and government showcasing case studies, cutting edge data, insight and perspective. Conference programs include a broad spectrum of topics including protein and antibody engineering, cancer immunotherapy, oncology, and emerging therapeutics. Guests of Polyplus-transfection Save $200 on Commercial Registrations / $100 on Academic / Hospital / Government Registrations with Keycode 1805PLY.

For more information, please have a look at the agenda and register now to meet the delivery experts. Our team will present two Posters focusing on FectoPRO® & PEIpro®, our transfection reagent especially designed for Bioproduction.

The convention will take place at Seaport World Trade Center:
1 Seaport Ln, Boston, MA 02210, USA

Would you like to have the opportunity to discuss with the scientist who developed FectoPRO in a more relaxed atmosphere?

Contact us!

Conference

Come and listen our Senior Scientist in Bioproduction, Mathieu Porte, during the Stream: « Expression », Session: « Difficult to express proteins » on May 1st at 3:20 pm. He will present the Development and Optimization of an Advanced Transient Expression System in CHO cells.

Posters: FectoPRO® & PEIpro®

Amazing Protein Production Yields in Transient CHO and HEK-293 Expression Systems with FectoPRO®

Transient protein expression is a common bioproduction process used to produce milligram to gram quantities of recombinant proteins and antibodies for a wide range of applications. However, when compared to stable expression platforms, the overall yield of transient protein expression remains weak, limiting its use in bioproduction processes. One of the manufacturing strategies for improving the transient productivity is then to increase transfection efficiency. We have developed a novel technologically advanced transfection solution, FectoPRO®, which outperforms currently available PEI-based and lipid-based transfection reagents. This poster presents data and protocol leading to remarkable protein and antibody yields in different transient CHO and HEK-293 expression systems.

PEIpro®: a Well Characterized PEI Optimized for an Efficient and Reliable Transient Protein Production

Transient protein expression in mammalian cell lines has gained increasing relevance as it enables fast and flexible production of high-quality eukaryotic protein. Milligram amounts of protein can be produced within several days, meaning a significant shortening of process time in comparison to protein production from stable clones. However, to ensure the robustness of the process, it is absolutely necessary to have a reliable transfection solution. That’s why we developed PEIpro®, an enhancement of the gold standard PEI, optimized for transient protein expression and perfectly suitable for the development of bioproduction processes with great scale-up predictability. In this poster, we present experimental data showing the benefits of using PEIpro® for protein production, and its efficiency in comparison to other PEIs.

Our team

Meet our team to discuss how to improve your Bioproduction system. We will be happy to answer all your questions regarding transfection and to present you relevant products adapted to your experiments.

Karsten Wilking Mathieu Porte Julien Depollier Guillaume Freund

Karsten Wilking

CEO

…. 

Mathieu Porte

Senior Scientist – Bioproduction

….

Julien Depollier

Business Director

….

Guillaume Freund

Scientific and Technical Support Specialist

Our solutions for Bioproduction

FectoPRO® Transfection kit is specifically designed for enhanced Transient Gene Expression (TGE) in suspension CHO and HEK-293 cells in various serum-free media, using low DNA amount (< 1 µg/ml of cell culture).

PEIpro® is a DNA transfection reagent for production of viruses, recombinant proteins and antibodies either in adherent cells in presence of serum or in suspension HEK-293 cells grown in low serum or serum-free media.

PEIpro®-HQ is a highly qualified grade of PEIpro® reagent, especially developed for the production of clinical batches of viral vectors or recombinant proteins and antibodies. The PEIpro®-HQ grade is supplied with appropriate Quality Controls and documentation allowing its use as a qualified raw material in GMP processes for the manufacturing of clinical batches of therapeutic products.

Join us on the social network

We created a dedicated event on Facebook to allow you to discuss with other scientists about the PEGS meeting or about your transfection experiments.

If you want to talk about this event (Facebook, Twitter, Google+, etc…), don’t forget to use the #PEGS18 and follow the PEGS news.